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BACKGROUND. Use of oral antiseptics decreases the bacterial load in the oral cavity. 
OBJECTIVE. To compare the antimicrobial activity of 3 novel oral antiseptics with that of chlorhexidine, which is considered the "gold 
standard" of oral hygiene. 
DESIGN. Comparative in vitro study. 
METHODS. Four common oral microorganisms (Streptococcus sanguinis, Streptococcus mutans, Candida albicans, and Fusobacterium nu-
cleatum) were tested under standard conditions and at different concentrations, by use of a broth dilution assay and an agar diffusion 
assay and by calculating the log10 reduction factor (RF). The antimicrobial activity of each antiseptic was assessed by counting the difference 
in bacterial densities (ie, the log10 number of colony-forming units of bacteria) before and after the disinfection process. 
RESULTS. The oral antiseptics containing octenidine (with an RF in the range of 7.1-8.24 CFU/mL) and polyhexamethylene biguanide 
(with an RF in the range of 7.1-8.24 CFU/mL) demonstrated antimicrobial activity comparable to that of chlorhexidine (with an RF in 
the range of 1.03-8.24 CFU/mL), whereas the mouth rinse containing Citroxx (Citroxx Biosciences; with an RF in the range of 0.22-1.36 
CFU/mL) showed significantly weaker antimicrobial efficacy. Overall, octenidine and polyhexamethylene biguanide were more active at 
lower concentrations. 
CONCLUSION. Oral antiseptics containing the antimicrobial agent octenidine or polyhexamethylene biguanide may be considered as 
potent alternatives to chlorhexidine-based preparations. 
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The mouth and oropharynx are colonized with microorgan- suited in a significant reduction in cases of ventilator-asso-
isms, which include gram-negative anaerobic bacteria, Staph- ciated pneumonia. 
ylococcus aureus, and Candida species. The most common Chlorhexidine is a cationic biguanide that was introduced 
oral infections associated with bacteria are diseases of the as an antimicrobial agent by G. E. Davies in 1954.6 Because 
tooth-supporting structures (ie, gingivitis and periodontitis), of the antimicrobial spectrum and the suspected remnant 
affecting up to 98% of adults in the United States.1 In ad- effect, chlorhexidine digluconate is considered the "gold stan-
dition, these microorganisms have the ability to invade the dard" of oral hygiene in the United States. However, the use 
bloodstream, resulting in transient bacteremia, especially dur- of chlorhexidine-containing mouth rinses can result in ad-
ing tooth brushing and flossing (20%-68% of cases) and even verse effects, such as taste disturbance or tooth staining, that 
during the chewing of food (7%-51% of cases). The micro- may have an impact on compliance. In addition to the cy-
organisms found in the oral cavity are also associated with totoxicity of chlorhexidine on corneal and endothelial cells,7 
pneumonia.2,3 A meta-analysis by Chan et al4 provided in- the neurotoxicity of chlorhexidine was observed in animal 
direct evidence of the impact of oral microorganisms; they models, which prevents it from being used for very long.8,9 
showed that oral decontamination with an antiseptic admin- Allergic reactions are common if chlorhexidine is applied in 
istered as prophylaxis reduces the incidence of ventilator- concentrations of more than 4%, and serious anaphylactic 
associated pneumonia. Similarly, a randomized controlled reactions have been described.10 A higher concentration of 
clinical trial5 showed that selective oral decontamination re- chlorhexidine would be preferable for mouth rinses because 
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they are diluted after application. However, there is evidence 
that the antimicrobial effect of chlorhexidine is primarily bac-
teriostatic, rather than bactericidal, and that the antimicrobial 
effect of chlorhexidine is probably overestimated because of 
lack of neutralization after sampling.11 In addition, its efficacy 
against several gram-negative pathogens is limited. 
In Europe, additional oral antimicrobial mouth rinses con-
taining octenidine, polyhexamethylene biguanide, or Citroxx 
(Citroxx Biosciences) have been marketed that claim to have 
a similar antimicrobial spectrum but are associated with fewer 
adverse effects, less toxicity, and less frequency of allergic 
reactions.12,13 Citroxx consists of a patented blend of bioflavi-
noids and fruit acids.14 Citroxx-containing solutions are fre-
quently used as active ingredients in a variety of applications, 
cosmetics, personal care products, or hand washes. 
In addition to polyhexamethylene biguanide's antibacterial 
activity against oral microorganisms,13 it has been used in 
antimicrobial gauze dressing to prevent surgical site infections 
due to methicillin-resistant S. aureus.15 Octenidine may be 
used for prolonged periods of time because it is associated 
with fewer adverse effects, compared with chlorhexidine. In 
the clinical setting, octenidine has been successfully used for 
the prevention of catheter-related infections.1216 
A standardized follow-up period, which included labora-
tory analysis of sessile and planktonic bacteria, was suggested 
for the evaluation of the antimicrobial activities of oral 
antiseptics.17,18 Finally, the therapeutic efficacy of each anti-
septic has to be evaluated in clinical studies (ie, with the use 
of phase 3 tests). 
However, to our knowledge, there have been no side-by-
side in vitro studies evaluating the antimicrobial efficacy of 
these 3 oral antiseptics, unlike those evaluating the antimi-
crobial efficacy of chlorhexidine. In addition, concerns have 
been raised about the emergence of microorganisms resistant 
to chlorhexidine, which appears not to be a clinical problem 
yet. The aim of the present in vitro study was to compare 
the antimicrobial activity of 3 commercially available, novel 
oral antiseptics (containing octenidine, polyhexamethylene bi-
guanide, or Citroxx, respectively) with that of chlorhexidine. 
METHODS 
Microorganisms and Growth Conditions 
The DSM 20068 strain of Streptococcus sanguinis and the DSM 
20523 strain of Streptococcus mutans were obtained from the 
Deutsche Sammlung von Mikroorganismen und Zellkultu-
ren, and the ATCC 90028 strain of Candida albicans and the 
ATCC 10953 strain of Fusobacterium nucleatum were obtained 
from the American Type Culture Collection. The strains were 
grown on Columbia blood agar plates (BBL; Becton Dick-
inson) supplemented with 50 mL/L of human blood, 0.5 mg/ 
L of menadione, and 5 mg/L of hemin at 37°C. C. albicans 
was incubated under aerobic conditions for 24 hours; S. mu-
tans was incubated in air with 10% C02 for 48 hours; S. 
sanguinis was incubated under anaerobic conditions with 10% 
C02, 10% H2, and 80% N2 for 24 hours; and F. nucleatum 
was incubated under anaerobic conditions for 48 hours. These 
conditions were used throughout our study. 
Preparation of Test Solutions 
The following 3 commercially available oral antiseptics were 
compared: Octenidol (Schiilke 8c Mayr AG), which contains 
octenidine as an antimicrobial agent; ProntOral (B. Braun 
Medical), which contains polyhexamethylene biguanide as an 
antimicrobial agent; and OralClens (Oraldent), which con-
tains Citroxx as an antimicrobial agent. The exact formulas 
for these mouth rinses are not in the public domain because 
of patent-related restrictions. Chlorhexidine digluconate so-
lution in a frequently used and recommended concentration 
(0.2%) (Sigma) served as a comparator. These commercially 
available mouth rinses were applied in their recommended 
concentration and also at serial dilutions down to 10~3 to test 
lower concentrations as they may occur during application. 
Broth Dilution Assay 
The test strains were suspended in 0.9% NaCl, harvested by 
centrifugation at 10,000 rpm (radius, 85 mm) for 5 minutes, 
and resuspended in 0.9% NaCl. The microbial suspensions 
were adjusted to a final cell density of approximately 6 x 
108 CFU/mL, controlled by plating appropriate dilutions of 
the suspensions onto the Columbia blood agar plates. An 
aliquot of 100 jiiL of a microbial suspension was added to 
900 juL of a test solution and mixed thoroughly. After in-
cubation at room temperature for 1 minute, the suspensions 
were serially diluted in 0.9% NaCl, and appropriate dilutions 
were plated onto Columbia blood agar media. The number 
of colony-forming units per milliliter was determined after 
strain-specific incubation, and the mean log10 CFU reduction 
factor was calculated. The antimicrobial activity of each an-
tiseptic was assessed by counting the difference in bacterial 
densities (ie, the log10 number of colony-forming units of 
bacteria) before and after the disinfection process. All ex-
periments were performed 3 times. 
Agar Diffusion Assay 
A modified agar diffusion assay was used.19 In brief, 20 LJL 
of undiluted or diluted mouth rinse was placed onto a blank, 
nonimpregnated filter-paper disk (bioMerieux; diameter, 6 
mm). Sterilized 0.9% NaCl served as a negative control. Sus-
pensions equal to the 0.5 McFarland standard for each bac-
terial strain and suspensions equal to 2-4 McFarland for C. 
albicans were prepared in broth medium: Sabouraud dextrose 
broth (Becton Dickinson) for C. albicans, Schaedler broth 
(Becton Dickinson) for S. mutans and S. sanguinis, and thio-
glycolate broth (Becton Dickinson) for F. nucleatum. After 
inoculating the suspensions evenly with a cotton swab onto 
Columbia blood agar plates, the disks were placed and gently 
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pressed on the plates with sterile forceps. After strain-specific 
incubation, all plates were photographed, and the inhibition 
zones were measured. All experiments were performed 3 
times. 
Statistical Analyses 
All analyses were done by use of the statistical package R, 
version 2.8 (The R Foundation for Statistical Computing). 
Prior to the statistical analyses, all colony-forming units per 
milliliter were log-transformed. Statistical comparisons were 
made for the results obtained for the undiluted mouth rinses. 
For each strain, linear regression models were performed, 
with "diameter" and "count reduction" as dependent factors 
and "treatment" as the independent factor. Pairwise differ-
ences in the mean values were calculated between each treat-
ment for each strain independently. Ninety-five percent con-
fidence intervals and 2-sided P values were calculated. P 
values of less than 0.05 were considered to be statistically 
significant. P values were adjusted for multiple comparisons 
according to the Tukey method. Box plots were prepared that 
show the dependency of the count reduction and the inhi-
bition zone on the treatment and concentration of the test 
solutions. The efficacy of a mouth rinse was calculated as a 
log10 reduction factor after the mouth rinse was exposed for 
1 minute in a broth medium. 
RESULTS 
In general, the antimicrobial activity of the mouth rinses 
containing octenidine and polyhexamethylene biguanide was 
comparable to that of chlorhexidine. In contrast, the mouth 
rinse containing Citroxx showed remarkably weaker anti-
microbial efficacy. Dose-dependent killing was observed in 
all experiments, whereas the cell counts of the negative control 
(ie, 0.9% NaCl) remained unaffected. 
S. sanguinis 
In both the broth dilution assay (Figure 1A) and the agar 
diffusion assay (Figure IB), similar antimicrobial activity 
against S. sanguinis was demonstrated by Octenidol and 
ProntOral. The broth dilution assay revealed that Octenidol 
and ProntOral were active against S. sanguinis even at very 
low concentrations, whereas chlorhexidine demonstrated 
only a moderate effect. In contrast, the undiluted chlorhex-
idine was the most effective solution in the agar diffusion 
assay. In the agar disk assay, the disks treated with undiluted 
OralClens showed an inhibition zone comparable to the disks 
treated with undiluted Octenidol or undiluted ProntOral. In 
the broth dilution assay, no antimicrobial efficacy was evident 
for OralClens (mean reduction factor, 0.26 CFU/mL). The 
mean reduction factor was 7.2 CFU/mL for undiluted Oc-
tenidol, 7.2 CFU/mL for undiluted ProntOral, and 1.03 CFU/ 
mL for undiluted chlorhexidine. In the broth dilution assay, 
there were statistically significantly lower microbial counts 
for chlorhexidine (P< .001) and OralClens (P< .001), com-
pared with ProntOral and Octenidol. The diameters of the 
inhibition zones were statistically significant for Octenidol, 
compared with chlorhexidine (P<.001) or ProntOral (P< 
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FIGURE 2. Box plot summarizing the log10 reduction of total microbial counts (ie, the reduction factor, in units of CFU/mL) and the 
diameters of the inhibition zones obtained when testing different concentrations of the mouth rinses against Streptococcus mutatis. The 
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.03); for OralClens, compared with ProntOral ( P < .03); and tenidol and ProntOral as low as 1% were able to kill this 
for chlorhexidine, compared with OralClens (P< .001). 
S. mutatis 
S. mutans was more susceptible to chlorhexidine, Octenidol, 
and ProntOral than was S. sanguinis. Concentrations of Oc-
microorganism in the broth dilution assay (Figure 2A). As 
with S. sanguinis, no reduction in the number of colony-
forming units per milliliter could be detected when S. mutans 
was treated with OralClens, whereas modest inhibitory ac-
tivity was shown in the agar diffusion assay (Figure 2B). The 
0 -
CHX 
o * 
Q 
a 
Octenidol 
A Q T 
H 
Oral Clens 
0 
S ep 5 
Pront Oral 
-r -r -r 
Qftft 
100 10 1 0.1 100 10 1 0.1 100 10 1 0.1 100 10 1 0.1 
Concentration, % 
B 
25 -
20 -
15 -
10 -
5 -
CHX 
• -
5 
• • • 
Octenidol 
* 
Oral Clens 
• • • * • 
Pront Oral 
s 
• • • • 
100 10 1 0.1 100 10 1 0.1 100 10 1 0.1 100 10 1 0.1 
Concentration, % 
FIGURE 3. Box plot summarizing the log10 reduction of total microbial counts (ie, the reduction factor, in units of CFU/mL) and the 
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mean reduction factor was 8.24 CFU/mL for undiluted Oc-
tenidol, 8.24 CFU/mL for undiluted ProntOral, 0.22 CFU/ 
mL for undiluted OralClens, and 8.24 CFU/mL for undilut-
ed chlorhexidine. A statistically significant difference in the 
reduction in microbial counts with chlorhexidine, Octeni-
dol, and ProntOral, compared with OralClens (P< .001), was 
found using the highest concentration of the mouth rinses 
in the broth dilution assay. In the agar diffusion assay, the 
inhibition zone for chlorhexidine was statistically significantly 
different from the inhibition zones for OralClens (P< .001), 
Octenidol (P< .001), and ProntOral (P< .001). The inhibi-
tion zones for Octenidol (P = .02) and ProntOral (P< 
.001) were statistically significantly different from the inhi-
bition zone for OralClens. 
F. nucleatum 
Both the broth dilution assay (Figure 3A) and the agar dif-
fusion assay (Figure 3B) showed that Octenidol, ProntOral, 
and chlorhexidine are effective against F. nucleatum. Pront-
Oral demonstrated remarkable antimicrobial efficacy even at 
the lowest concentration in the broth dilution assay. Chlor-
hexidine and Octenidol were also potent against F. nucle-
atum, whereas OralClens showed only a minor killing effect 
in the broth dilution assay and failed to inhibit growth in 
the agar diffusion assay. The mean reduction factor was 7.1 
CFU/mL for undiluted Octenidol, 7.1 CFU/mL for undilut-
ed ProntOral, 1.36 CFU/mL for undiluted OralClens, and 
7.1 CFU/mL for undiluted chlorhexidine. Compared with 
OralClens, when the highest concentrations of chlorhex-
idine (P<.001), Octenidol (P<.001), and ProntOral (P< 
.001) were used in the broth dilution assay, the reductions in 
microbial counts were statistically significant. The diameters 
of the inhibition zones on the disks treated with chlorhexi-
dine, OralClens, Octenidol, and ProntOral differed statisti-
cally significantly in the agar diffusion assay, depending on 
whether the highest concentration of the mouth rinses or the 
chlorhexidine control solution was used (OralClens vs chlor-
hexidine, ProntOral, and Octenidol [P< .001]; Octenidol vs 
ProntOral [P = .02]; chlorhexidine vs Octenidol and Pront-
Oral [P<.001]). 
C. albicans 
ProntOral, Octenidol, and chlorhexidine were effective even 
at low concentrations in the broth dilution assay (Figure 4A) 
and in the agar diffusion assay (Figure 4B). Only the undi-
luted OralClens showed inhibition in the agar diffusion assay. 
The mean reduction factor was 7.54 CFU/mL for undiluted 
Octenidol, 7.54 CFU/mL for undiluted ProntOral, 0.35 CFU/ 
mL for undiluted OralClens, and 7.54 CFU/mL for undiluted 
chlorhexidine. Statistically significant differences in the re-
duction in microbial counts with chlorhexidine, OralClens, 
and ProntOral, compared with OralClens (P<.001), were 
found using the highest concentrations of the solutions in 
the broth dilution assay. In the agar diffusion assay, statis-
tically significant differences were found for disks treated with 
ProntOral, compared with OralClens (P = .01), Octenidol 
(P = .01), and chlorhexidine (P = .01). 
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DISCUSSION 
Our in vitro study clearly demonstrated that the efficacy of 
the mouth rinses containing octenidine or polyhexamethylene 
biguanide (but not Citroxx) was to similar the efficacy of 
chlorhexidine. Octenidine and polyhexamethylene biguanide 
remained very active even when highly diluted. In contrast, 
chlorhexidine lost its antimicrobial efficacy when diluted to 
less than 10% of its original concentration. Therefore, it is 
conceivable that such mouth rinses are at least as effective as 
chlorhexidine, on basis of these in vitro experiments. In fact, 
these products may be even more effective than chlorhexi-
dine, because many-fold dilutions are to be expected in 
mouth rinses that are used by the general public. Similar to 
chlorhexidine, octenidine and polyhexamethylene biguanide 
have prolonged effects after application. 
The oral cavity is the natural habitat of a wide variety of 
microorganisms.20 Some of them may be beneficial to the 
host, while others are considered to play a role in the path-
ogenesis of certain oral or other infectious diseases, including 
ventilator-associated pneumonia.20"23 Ideally, microorganisms 
beneficial to the host should not be affected by an antiseptic. 
The selection of the species in the present study represents 
some of the microorganisms with documented key charac-
teristics in the oral habitat or for the pathogenesis of pleu-
ropulmonary infections. S. sanguinis is commonly found in 
the oral cavity, is not considered pathogenic, and may be 
beneficial to the host. This bacterium is thought to dem-
onstrate a competitive inhibition of S. mutans,24,25 whereas S. 
mutans is closely related to the pathogenesis of caries.22 F. 
nucleatum, a gram-negative anaerobic rod, is an important 
link between the primary and secondary colonizers in the 
dental plaque and is detected in chronic periodontitis lesions 
and frequently recovered from patients with necrotizing-ul-
cerative gingivitis and/or periodontitis.23,26 In contrast to the 
treatment of chronic periodontitis, emergency treatment of 
necrotizing-ulcerative gingivitis and/or periodontitis consists 
of mechanical debridement with adjunctive use of antiseptics. 
F. nucleatum may also cause ventilator-associated pneumonia 
or other severe infections.2,27 The yeast C. albicans lives in a 
state of commensalism in the oral cavity but is also an im-
portant opportunistic pathogen that can cause infections 
varying from harmless newborn thrush to severe deep mu-
cocutaneous candidiasis or even sepsis in patients with a local 
or systemic compromised immune response or in patients 
who take antibiotics.28"30 
Our investigation has revealed that the killing efficacy of 
chlorhexidine against S. sanguinis was weaker than that of 
mouth rinses containing octenidine or polyhexamethylene 
biguanide (Figure 1). This finding is in accordance with that 
of Decker et al.31 In ascending order, the following mouth 
rinses were found to be the most effective against S. mutans: 
those containing chlorhexidine, those containing polyhexa-
methylene biguanide, and those containing octenidine. This 
confirms the recent findings of the comparative antimicrobial 
efficacy of octenidine and chlorhexidine in saliva (Figure 2).32 
Thus, octenidine killed streptococci most efficiently, whereas 
polyhexamethylene biguanide demonstrated superior anti-
fungal activity and control of anaerobic gram-negative F. nu-
cleatum (Figures 3 and 4). The mouth rinse containing Ci-
troxx, which consists of natural antimicrobial agents (in-
cluding bioflavinoids and fruit acids), demonstrated signifi-
cantly weaker antimicrobial efficacy than did the other agents 
tested. Therefore, its usefulness in antimicrobial mouth rinses 
is questionable. 
Clinical studies have shown that mouth rinses containing 
octenidine are effective in the control of dental plaque.33,34 
The efficacy of polyhexamethylene biguanide with regard to 
bacterial counts, dental plaque, and the 4-day regrowth of 
plaque has also been investigated.35,36 This antimicrobial agent 
seems to inhibit plaque recolonization and to reduce oral 
bacterial counts. The present in vitro data are in accordance 
with previous clinical reports. However, the nature of the 
present study is not just confirmatory, because the relative 
efficacy of these novel and commercially available mouth 
rinses has hitherto not been tested. Although the antimi-
crobial agents were given, the exact formulas of the mouth 
rinses were not available. Thus, the mode of action of the 
Vagents given may have been affected by interactions with oth-
er ingredients. 
No neutralizing agent was used in the current investigation, 
which might be a critical issue (because of the possible pro-
longed effect of the tested agent) that could probably lead to 
higher observed reduction factors. However, all of the com-
pounds were tested using the exact same assays and test con-
ditions, indicating valid results. In practice, mouth rinses are 
used for 30 seconds to 1 minute and then are spit out. Most 
chemical compounds (including chlorhexidine, octenidine, 
and polyhexamethylene biguanide) are very tenacious, which 
means that they bind well to tissue (resulting in a depot 
effect). Within the limitations of our in vitro study, we found 
the mouth rinses containing octenidine or polyhexamethyl-
ene biguanide to be potent alternative oral antiseptics to 
chlorhexidine. 
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